![]() |
![]() |
||||||||
|
Topical Drug DeliveryFORMULATION DEVELOPMENTAnalytical method developmentMedPharm can develop a suitable analytical method or use a method provided by the client.
(See Analytical Services) Pre-formulation / Formulation development and optimisationMedPharm will identify a range of excipients, which are suitable to achieve the formulation target, and will then test compatibility of these excipients with the drug.
Formulation optimisation – release and deposition testingA crucial step in formulation development is to achieve optimum release of the drug from the matrix in an in-use situation. Particularly with topical administration, a formulation is a major factor for controlling extent and rate of drug release, and thus for maximising bioavailability. MedPharm have an in-depth understanding of the mechanisms involved in controlling drug release from topical formulations. (See in-vitro performance testing) Formulation optimisation – efficacy screeningFormulations developed and refined using the release tests can also be screened for their efficacy in-vitro. For this purpose, MedPharm have developed a number of microbiological models, which allow bacterial or fungal skin and nail infections to be simulated. (See in-vitro performance testing) Laboratory scale stability studiesStability indicating drug assays can be developed and stability testing (physical, chemical and microbiological) performed to ICH guidelines. Packaging Material and CompatibilityPrimary packaging material can be selected in agreement with the client and compatibility can be tested with the selected formulations. Pre-clinical and clinical trialsMedPharm can supply GLP and/or GMP samples for pre-clinical and/or clinical investigation.
|
![]() |